Brain & Behavior Research Foundation Announces Webinars Will Feature Personality Disorder, Addiction, Depression, Mood Disorders, Schizophrenia & Autism
NEW YORK, June 25, 2015 /PRNewswire-USNewswire/ — The Brain & Behavior Research Foundation today announced new topics for its monthly webinar series during which leading mental health researchers discuss and answer questions about the latest in new technologies, early intervention strategies and next-generation therapies for brain and behavior disorders and mental illness.
The lineup includes researchers from Harvard Medical School, the National Institute of Drug Abuse, Cold Spring Harbor Laboratory,University of California Los Angeles, University of Texas Southwestern Medical School and Mount Sinai School of Medicine discussing the latest findings in borderline personality disorder, addiction, depression, mood disorders, schizophrenia and autism, respectively.
“These popular webinars offer caregivers, families and loved ones access to some of the world’s top scientists who discuss cutting-edge research that could lead to breakthroughs which will help alleviate much of the suffering caused by mental illness,” said Dr.Jeffrey Borenstein, M.D., President & CEO of the Brain & Behavior Research Foundation and host of the award-winning public television series “Healthy Minds.”
Each of the hour-long webinars moderated by Dr. Borenstein includes a presentation by the noted researchers, followed by an opportunity for audience Q&A. Each webinar will be live tweeted with the hashtag #brainchat. After the live event, recordings of the webinars will be available on the Foundation’s website at: bbrfoundation.org/meet-the-scientist-webinar-series.
The upcoming webinars are:
July 14, 2-3 p.m. EDT
BORDERLINE PERSONALITY DISORDER
D. Bradford Reich, M.D., McLean Hospital and Assistant Clinical Professor of Psychiatry Harvard Medical School, will discuss his research on the neurobiological distinction between the two conditions and his hypothesis that emotional instability in borderline patients involves increased activity in the amygdala and decreased activity in the anterior cingulate cortex, and that emotional instability in bipolar II patients involves decreased activity in the ventrolateral prefrontal cortex.